// App-Quantinova.ai

: Prolonged Maintenance of Ex Vivo Functional Vk*MYC Multiple Myeloma Cells Allows for in Vitro Manipulation and Subsequent In Vivo Analysis

Researchers

Presenter

  • Frances E Lock

Principal Investigators

  • Afsaneh Panahi

  • Ariene Cabantog

  • Lorenzo Lindo

  • Daniel Waller

  • Kevin Hay

  • Marta Chesi

  • Arefeh Rouhi

  • Florian Kuchenbauer

Medical Centers

  • Faculty of Medicine, University of British Columbia, Vancouver, Canada

  • Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, Canada

  • Mayo Clinic, Scottsdale, AZ

  • The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Primary plasma cell leukemia

  • Multiple Myeloma

Biomarkers

  • cMYC

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved